Late-stage deuteration and tritiation through bioinspired cooperative hydrogenolysis

被引:0
|
作者
Zhang, Beibei [1 ]
Zhang, Zhenyang [1 ]
Wang, Yang [1 ,2 ]
Zhao, Da [1 ,2 ]
机构
[1] Univ Chinese Acad Sci, Sch Chem Sci, Beijing, Peoples R China
[2] Binzhou Inst Technol, Weiqiao UCAS Sci & Technol Pk, Binzhou, Peoples R China
来源
基金
中国国家自然科学基金;
关键词
ISOTOPE-EXCHANGE; ACTIVATION; FUNCTIONALIZATION; DEHALOGENATION; HYDROGENATION; PHOTOREDOX;
D O I
10.1038/s44160-024-00716-0
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Hydrogenolysis, a fundamental chemical process with broad applications, has traditionally been performed using heterogeneous catalysis at high temperatures and pressures with limited selectivity. Recent advancements highlight the potential of homogeneous catalysis as a promising alternative, offering improved selectivity under milder conditions. However, the development of a general homogeneous catalysis approach capable of hydrogenolysing carbon-halogen bonds-one of the most fundamental, versatile and extensively studied functional groups-remains an unresolved challenge. Here we present a comprehensive rationale for the fundamental mechanistic prerequisites crucial to achieving general homogeneous carbon-halogen bond hydrogenolysis, with a particular focus on the tritiation of challenging yet abundant alkyl chlorides. We demonstrate how cooperative interplay of bioinspired carbon-halogen activation and hydrogenation can efficiently catalyse the selective hydrogenolysis of unactivated organohalides. The utility of this approach is demonstrated through its capability to enable deuteration and tritiation of pharmaceutically relevant organohalides with simultaneous control over reactivity and selectivity.
引用
收藏
页码:444 / 452
页数:9
相关论文
共 50 条
  • [41] Palladium(II)-Catalyzed Nondirected Late-Stage C(sp2)-H Deuteration of Heteroarenes Enabled Through a Multi-Substrate Screening Approach
    Dey, Jyotirmoy
    Kaltenberger, Simon
    van Gemmeren, Manuel
    ANGEWANDTE CHEMIE-INTERNATIONAL EDITION, 2024, 63 (27)
  • [42] Nutraceutical use in late-stage cancer
    Michael J. Wargovich
    Jay Morris
    Vondina Brown
    Jane Ellis
    Britt Logothetis
    Rebecca Weber
    Cancer and Metastasis Reviews, 2010, 29 : 503 - 510
  • [43] SANOFI OVERHAULS LATE-STAGE PIPELINE
    不详
    CHEMICAL & ENGINEERING NEWS, 2009, 87 (18) : 22 - 22
  • [44] COMMUNICATION AND LATE-STAGE CANCER PATIENT
    KRANT, MJ
    JOHNSTON, L
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1976, 17 (MAR): : 251 - 251
  • [45] PALLIATIVE CARE IN LATE-STAGE CANCER
    KRANT, MJ
    GRIFFIN, TW
    DOSTER, NJ
    GODKIN, MA
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1979, 20 (MAR): : 393 - 393
  • [46] Late-stage borreliosis and substance abuse
    Bransfield, Robert C.
    Gadila, Shiva Kumar Goud
    Kursawe, Laura J.
    Dwork, Andrew J.
    Rosoklija, Gorazd
    Horn, Elizabeth J.
    Cook, Michael J.
    Embers, Monica E.
    HELIYON, 2024, 10 (10)
  • [47] Late-stage fluorination for PET imaging
    Ritter, Tobias
    JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS, 2018, 61 (05): : 458 - 458
  • [48] Membrane instability in late-stage erythropoiesis
    Waugh, RE
    Mantalaris, A
    Bauserman, RG
    Hwang, WC
    Wu, JHD
    BLOOD, 2001, 97 (06) : 1869 - 1875
  • [49] Late-Stage Diversification of Natural Products
    Hong, Benke
    Luo, Tuoping
    Lei, Xiaoguang
    ACS CENTRAL SCIENCE, 2020, 6 (05) : 622 - 635
  • [50] Personalized medicines in late-stage development
    Christopher-Paul Milne
    Steve Garafalo
    Crystal Bryan
    Marie McKiernan
    Nature Reviews Drug Discovery, 2014, 13 : 324 - 325